
Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).
Analyst Matthew Henriksson, has had 100% of price targets met with an average potential upside of 17.02%, reached in 400 days on average. Previously, Matthew Henriksson worked at CITI.
Matthew Henriksson has documented 8 price targets and ratings displayed on 1 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.
Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) on 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%), with a performance score of 1.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2025
$90
$23.11 (34.55%)
$100
13 days ago
(09-Nov-2026)
34/38 (89.47%)
$13.63 (17.85%)
357
Buy Since 17-Dec-2025
$105
$38.11 (56.97%)
$112
16 days ago
(06-Nov-2026)
0/3 (0%)
$33.95 (47.78%)
Buy Since 06-Nov-2024
$78
$11.11 (16.61%)
$104
16 days ago
(06-Nov-2026)
14/16 (87.5%)
$6.95 (9.78%)
264
Buy Since 06-Apr-2020
$100
$33.11 (49.50%)
$99
16 days ago
(06-Nov-2026)
9/13 (69.23%)
$28.95 (40.75%)
210
Buy Since 25-Feb-2026
$100
$33.11 (49.50%)
$117
16 days ago
(06-Nov-2026)
3/7 (42.86%)
$28.95 (40.75%)
499